64407564MMY3009: A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pom
64407564MMY3009: A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pom
The purpose of this study is to compare the effectiveness of either talquetamab plus pomalidomide (Tal-P) or talquetamab plus teclistamab (Tal-Tec) with elotuzumab, pomalidomide, and dexamethasone (EPd) or pomalidomide, bortezomib, and dexamethasone (PVd).
Inclusion Criteria:
Exclusion Criteria:
Baltimore, Maryland 21287, United States
Hackensack, New Jersey 07601, United States
Pittsburgh, Pennsylvania 15232, United States
CABA, C1118AAT, Argentina
Rio de Janeiro, 22793-080, Brazil
São José do Rio Preto, 15090 000, Brazil
Montreal, Quebec H1T 2M4, Canada
Shanghai, 200025, China
Budapest, 1097, Hungary
Alessandria, 15121, Italy
Nishinomiya Shi, 663 8501, Japan
Shibuya-ku, 150-8935, Japan
Shiwa-gun, 028-3695, Japan
Sunto Gun, 411 8777, Japan
Brzozów, 36-200, Poland
Szczecin, 71-252, Poland
Jeollanam-do, 58128, South Korea
Asturias, 33394, Spain
Ankara, 06620, Turkey (Türkiye)